Ophthalmology Times: October 1, 2021

Ongoing nationwide study looks at in vitro antibiotic resistance among isolates.

Sustained-release option is deposited directly into the lenticular capsule.

Patients can get real-time disease monitoring with self-operated device.

Improvements are seen after gene therapy for Leber congenital amaurosis.

Investigators have found that the early and late stages of uveal melanoma differ markedly.

Three cases demonstrate value of new tools, technology for surgeons.

According to investigators, aqueous humor analysis differentiated the tumors in patients.

There are times when physicians should be critical of scans.

Sustained-release option helps with patient adherence following surgery.

Nasotemporal sagittal height asymmetry a good biomarker of shortsightednes.

Lens an option for complicated eyes, astigmatism, monovision candidates.

Eric Donnenfeld, MD, presents results of the year-long Grail Study demonstrating the safety and performance of the Juvene IOL from LensGen Inc.